Transhuman Capital is a venture capital firm founded in 2014 that invests in therapeutics and related medical technologies, backing seed through crossover-stage biotechnology companies. Its activity spans early-stage and later-stage venture opportunities in life sciences, biotechnology, pharmaceuticals, medical devices, HealthTech and oncology, with U.S. investment exposure.